TY - JOUR
KW - *Cardiovascular Diseases/epidemiology/prevention & control
KW - *Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology
KW - *Dipeptidyl-Peptidase IV Inhibitors/therapeutic use
KW - England
KW - Female
KW - Germany
KW - Glucose
KW - Humans
KW - Japan
KW - Middle Aged
KW - Norway
KW - Republic of Korea
KW - Sodium
KW - *Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
KW - Sweden/epidemiology
KW - DPP-IV inhibitor
KW - SGLT2 inhibitor
KW - dapagliflozin
KW - diabetic nephropathy
KW - heart failure
KW - Observational study
AU - K. Birkeland
AU - J. Bodegard
AU - A. Banerjee
AU - D. Kim
AU - A. Norhammar
AU - J. Eriksson
AU - M. Thuresson
AU - S. Okami
AU - K. Ha
AU - N. Kossack
AU - J. Mamza
AU - R. Zhang
AU - T. Yajima
AU - I. Komuro
AU - T. Kadowaki
AD - Oslo University Hospital and University of Oslo, Oslo, Norway.
AstraZeneca, Oslo, Norway.
Institute of Health Informatics, University College London, London, UK.
Department of Cardiology, University College London Hospitals, London, UK.
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.
Cardiology Unit, Department of Medicine, Karolinska Institute, Solna, Sweden.
Capio S:t Görans Hospital, Stockholm, Sweden.
Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Statisticon AB, Uppsala, Sweden.
AstraZeneca, Osaka, Japan.
Wissenschaftliches Institut für Gesundheitsökonomie und Gesundheitssystemforschung, Leipzig, Germany.
AstraZeneca, Luton, UK.
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tranomon Hospital, Tokyo, Japan.
AN - 32893440
BT - Diabetes Obes Metab
C2 - PMC7756303
DO - 10.1111/dom.14189
DP - NLM
ET - 2020/09/08
LA - eng
M1 - 1
N1 - 1463-1326
Birkeland, Kåre I
Orcid: 0000-0003-3002-6933
Bodegard, Johan
Orcid: 0000-0001-5423-3967
Banerjee, Amitava
Kim, Dae Jung
Orcid: 0000-0003-1025-2044
Norhammar, Anna
Eriksson, Jan W
Orcid: 0000-0002-2639-9481
Thuresson, Marcus
Okami, Suguru
Orcid: 0000-0003-4402-0209
Ha, Kyoung Hwa
Kossack, Nils
Mamza, Jil Billy
Zhang, Ruiqi
Yajima, Toshitaka
Komuro, Issei
Kadowaki, Takashi
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Diabetes Obes Metab. 2021 Jan;23(1):75-85. doi: 10.1111/dom.14189. Epub 2020 Sep 28.
PY - 2021
SN - 1462-8902 (Print)1462-8902
SP - 75
EP - 85
T2 - Diabetes Obes Metab
TI - Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
VL - 23
ER -